{"id":"therapeutic-anticoagulation","safety":{"commonSideEffects":[{"rate":"2-5%","effect":"Major bleeding"},{"rate":"1-2%","effect":"Gastrointestinal bleeding"},{"rate":"1-2%","effect":"Hemorrhage"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved through the modulation of the coagulation cascade, which is a complex process involving multiple enzymes and proteins. Therapeutic anticoagulants work by either inhibiting the production of thrombin or preventing the formation of fibrin clots.","oneSentence":"Therapeutic anticoagulation involves the inhibition of blood clot formation to prevent thrombotic events.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:38:31.054Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of stroke and systemic embolism in non-valvular atrial fibrillation"},{"name":"Treatment and prevention of deep vein thrombosis and pulmonary embolism"}]},"trialDetails":[{"nctId":"NCT03568890","phase":"PHASE4","title":"Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2018-09-01","conditions":"Left Atrial Appendage Closure, Thrombosis, Stroke","enrollment":510},{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT05758077","phase":"NA","title":"Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury","status":"RECRUITING","sponsor":"SeaStar Medical","startDate":"2023-04-17","conditions":"Acute Kidney Injury","enrollment":339},{"nctId":"NCT07262255","phase":"NA","title":"WATCHMAN FLX Pro European Registry","status":"RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2025-12-17","conditions":"Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure","enrollment":1000},{"nctId":"NCT06753786","phase":"NA","title":"Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2024-10-21","conditions":"Venous Thromboembolism, Pulmonary Embolism, Intracerebral Hemorrhage","enrollment":200},{"nctId":"NCT07487532","phase":"NA","title":"Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-04-01","conditions":"Atrial Fibrillation (AF)","enrollment":120},{"nctId":"NCT02928497","phase":"NA","title":"Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2017-02-06","conditions":"Stroke","enrollment":481},{"nctId":"NCT04996667","phase":"PHASE2","title":"Effect of iNO in Patients With Submassive and Massive PE","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2026-06-01","conditions":"Pulmonary Embolism, Pulmonary Embolism Subacute Massive","enrollment":""},{"nctId":"NCT04907825","phase":"PHASE4","title":"A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2023-03-13","conditions":"Atrial Fibrillation, Stroke","enrollment":14},{"nctId":"NCT04077463","phase":"PHASE1","title":"A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-09-04","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":701},{"nctId":"NCT05900388","phase":"","title":"A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)","status":"NOT_YET_RECRUITING","sponsor":"Bayer","startDate":"2026-09-01","conditions":"Venous Thromboembolism, Children Under 2 Years","enrollment":850},{"nctId":"NCT07467889","phase":"","title":"Impact of CRRT on Serum Carnitine and Micronutrient Levels","status":"COMPLETED","sponsor":"Gulhane Training and Research Hospital","startDate":"2023-01-01","conditions":"Acute Kidney Injury (Nontraumatic), Critical Illness","enrollment":43},{"nctId":"NCT07456085","phase":"PHASE3","title":"Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves","status":"ENROLLING_BY_INVITATION","sponsor":"Rawalpindi Institute of Cardiology","startDate":"2025-11-13","conditions":"Valvular Heart Disease Patients","enrollment":60},{"nctId":"NCT07299695","phase":"PHASE3","title":"Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Argyrios Tzouvelekis","startDate":"2026-01-25","conditions":"Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":196},{"nctId":"NCT06883864","phase":"NA","title":"Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-04-08","conditions":"Atrial Fibrillation (AF), Catheter Ablation, Atrial Functional Mitral Regurgitation","enrollment":146},{"nctId":"NCT07469072","phase":"PHASE2","title":"Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2026-02-25","conditions":"Continuous Renal Replacement Therapy (CRRT)","enrollment":92},{"nctId":"NCT04618913","phase":"","title":"Anticoagulation in Patients With Venous Thromboembolism and Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2020-12-14","conditions":"Neoplasms, Embolism","enrollment":1},{"nctId":"NCT05038228","phase":"","title":"High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2022-08-01","conditions":"Atrial Fibrillation","enrollment":1},{"nctId":"NCT05047172","phase":"PHASE3","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-08-02","conditions":"Intracranial Arteriosclerosis, Stroke","enrollment":1683},{"nctId":"NCT06588634","phase":"NA","title":"The PERSEVERE Study","status":"RECRUITING","sponsor":"Inari Medical","startDate":"2024-12-16","conditions":"Pulmonary Embolism, Pulmonary Thromboembolism","enrollment":200},{"nctId":"NCT07458672","phase":"NA","title":"TAVR for Aortic Regurgitation Under TTE Guidance","status":"NOT_YET_RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2026-03-10","conditions":"Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR)","enrollment":30},{"nctId":"NCT06901466","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-06-13","conditions":"Mitral Regurgitation","enrollment":880},{"nctId":"NCT03297281","phase":"NA","title":"Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)","status":"RECRUITING","sponsor":"Clinique Pasteur","startDate":"2017-10-30","conditions":"Benign Prostatic Hyperplasia, Anticoagulant Adverse Reaction","enrollment":389},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT06871228","phase":"NA","title":"Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-08-05","conditions":"Atrial Fibrillation (AF)","enrollment":4100},{"nctId":"NCT06055920","phase":"NA","title":"The PEERLESS II Study","status":"RECRUITING","sponsor":"Inari Medical","startDate":"2023-11-17","conditions":"Pulmonary Embolism","enrollment":1200},{"nctId":"NCT07436702","phase":"","title":"Optimal Time for Reperfusion in Acute Pulmonary Embolism","status":"RECRUITING","sponsor":"Azienda ULSS 8 Berica","startDate":"2025-11-25","conditions":"Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute","enrollment":500},{"nctId":"NCT07441382","phase":"NA","title":"Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-01","conditions":"Atrial Fibrillation (AF), Stroke, Hemorrhage","enrollment":200},{"nctId":"NCT03041805","phase":"","title":"Caprini Score in Venous Surgery: a Prospective Cohort Study","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2017-01-01","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":3000},{"nctId":"NCT07432529","phase":"PHASE3","title":"Design and Rationale of the COLT Study","status":"NOT_YET_RECRUITING","sponsor":"Azienda Sanitaria Locale ASL 6, Livorno","startDate":"2026-06-01","conditions":"Venous Thrombosis Deep (Limbs), Post-thrombotic Syndrome, Venous Thromboembolism (VTE)","enrollment":940},{"nctId":"NCT07242326","phase":"","title":"SNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)","status":"ENROLLING_BY_INVITATION","sponsor":"Kotyora Family Medicine Health Management and Education Association","startDate":"2025-12-15","conditions":"Medication Adherence, Atrial Fibrillation (AF), Direct Oral Anticoagulants (DOACs)","enrollment":1000},{"nctId":"NCT05976685","phase":"NA","title":"Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-05-01","conditions":"Ischemic Stroke, Atrial Fibrillation","enrollment":482},{"nctId":"NCT07422701","phase":"","title":"Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2026-02-01","conditions":"Portal Vein Thrombosis, Liver Cirrhosis","enrollment":2522},{"nctId":"NCT06087952","phase":"NA","title":"Leiden Thrombosis Recurrence Risk Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2021-06-18","conditions":"Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism","enrollment":608},{"nctId":"NCT06533345","phase":"NA","title":"VCOM Pain Free Research Collaborative","status":"RECRUITING","sponsor":"Edward Via Virginia College of Osteopathic Medicine","startDate":"2024-08-30","conditions":"Chronic Pain","enrollment":120},{"nctId":"NCT07419802","phase":"","title":"OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study","status":"RECRUITING","sponsor":"Pauls Stradins Clinical University Hospital","startDate":"2026-03-01","conditions":"Sepsis, Septic Shock, Blood Purification","enrollment":29},{"nctId":"NCT05836987","phase":"PHASE3","title":"The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-07-13","conditions":"Atrial Fibrillation","enrollment":5350},{"nctId":"NCT07326215","phase":"NA","title":"A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+","status":"RECRUITING","sponsor":"Vantive Health LLC","startDate":"2025-12-11","conditions":"Acute Respiratory Distress Syndrome, Acute Kidney Injury","enrollment":99},{"nctId":"NCT05825573","phase":"PHASE3","title":"Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-05-15","conditions":"Intracardiac Thrombus, STEMI, Heart Failure","enrollment":340},{"nctId":"NCT05498428","phase":"PHASE2","title":"A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-11-11","conditions":"Carcinoma, Non-small-Cell Lung","enrollment":520},{"nctId":"NCT07399977","phase":"NA","title":"Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2026-01-30","conditions":"Venous Thromboembolism, Deep Venous Thrombosis","enrollment":259},{"nctId":"NCT06396858","phase":"PHASE4","title":"Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Brazilian Clinical Research Institute","startDate":"2026-07","conditions":"Ischemic Stroke","enrollment":4500},{"nctId":"NCT07404436","phase":"PHASE4","title":"Rivaroxaban in Idiopathic Membranous Nephropathy","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-01-05","conditions":"Idiopathic Membranous Nephropathy","enrollment":134},{"nctId":"NCT06429332","phase":"PHASE4","title":"International Care Bundle Evaluation in Cerebral Hemorrhage Research","status":"RECRUITING","sponsor":"Region Skane","startDate":"2025-01-07","conditions":"Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage","enrollment":3500},{"nctId":"NCT07372716","phase":"NA","title":"Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2026-03","conditions":"Thrombosis, Cancer, Thrombosis, Deep Vein","enrollment":700},{"nctId":"NCT07139314","phase":"NA","title":"Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2025-09-24","conditions":"Ischemic Stroke, Atrial Fibrillation","enrollment":240},{"nctId":"NCT06196307","phase":"","title":"Early Warning and Classification Model for Acute Non-traumatic Chest Pain","status":"RECRUITING","sponsor":"Xiao-nan He","startDate":"2022-08-30","conditions":"Chest Pain","enrollment":10000},{"nctId":"NCT07005024","phase":"PHASE3","title":"DOAC - Dosing Options in AntiCoagulation Prophylaxis","status":"RECRUITING","sponsor":"University of Vermont","startDate":"2025-10-17","conditions":"Cancer, VTE (Venous Thromboembolism)","enrollment":996},{"nctId":"NCT07139301","phase":"NA","title":"Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2025-09-04","conditions":"Ischemic Stroke, Atrial Fibrillation","enrollment":438},{"nctId":"NCT05701917","phase":"NA","title":"DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis","status":"RECRUITING","sponsor":"Inari Medical","startDate":"2023-01-06","conditions":"Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome","enrollment":300},{"nctId":"NCT05848713","phase":"PHASE3","title":"AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-10-10","conditions":"Community-acquired Pneumonia","enrollment":4000},{"nctId":"NCT07374978","phase":"NA","title":"Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-07-01","conditions":"Pulmonary Embolism Subacute Massive, Thrombolytic Therapy","enrollment":100},{"nctId":"NCT06080074","phase":"PHASE2","title":"Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System","status":"RECRUITING","sponsor":"Stanford University","startDate":"2025-04-15","conditions":"Heart Failure, Cardiogenic Shock, Congenital Heart Disease","enrollment":50},{"nctId":"NCT06486181","phase":"PHASE4","title":"Second Line Endovascular Treatment in Acute DVT","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-04-01","conditions":"Deep Venous Thrombosis","enrollment":100},{"nctId":"NCT06909240","phase":"NA","title":"Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)","status":"RECRUITING","sponsor":"Hvidovre University Hospital","startDate":"2025-11-15","conditions":"Deep Vein Thrombosis (DVT)","enrollment":152},{"nctId":"NCT07236463","phase":"PHASE1, PHASE2","title":"Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2026-02-01","conditions":"Acute Kidney Injury, Sepsis","enrollment":14},{"nctId":"NCT04113421","phase":"","title":"Quantitative 3-Dimensional Chest CT Vascular Reconstruction Before and After Anticoagulation for Pulmonary Embolism","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2019-12-01","conditions":"Pulmonary Embolism","enrollment":10},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT07352358","phase":"PHASE4","title":"Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-30","conditions":"Cerebral Venous Thrombosis","enrollment":72},{"nctId":"NCT04273607","phase":"PHASE2, PHASE3","title":"Anticoagulation-free VV ECMO for Acute Respiratory Failure","status":"RECRUITING","sponsor":"Damian Ratano","startDate":"2022-09-01","conditions":"Extracorporeal Membrane Oxygenation Complication","enrollment":40},{"nctId":"NCT07343895","phase":"NA","title":"Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tromsø Study","status":"RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2025-10-24","conditions":"Atrial Fibrillation (AF), Stroke, NT-pro-BNP","enrollment":4000},{"nctId":"NCT06440317","phase":"","title":"Immunothrombosis With Septic Shock Undergoing Renal Replacement Therapy With the OXIRIS Membrane","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2026-04","conditions":"Sepsis","enrollment":30},{"nctId":"NCT07342127","phase":"","title":"Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-02-01","conditions":"Factor V Leiden Heterozygous Mutation, Factor II Heterozygous Mutation, Pregnancy","enrollment":100},{"nctId":"NCT07335770","phase":"","title":"Cardiac Magnetic Resonance for Diagnosis, Treatment Guidance and Prognosis of Cardiac Masses (CMR)","status":"ENROLLING_BY_INVITATION","sponsor":"Minjie Lu","startDate":"2008-01-01","conditions":"Cardiac Masses","enrollment":2000},{"nctId":"NCT07330869","phase":"","title":"Warfarin Effects on Male Fertility After Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Città di Lecce Hospital, GVM Care & Research","startDate":"2026-02","conditions":"Male Infertility, Heart Valve Disease","enrollment":90},{"nctId":"NCT06842147","phase":"NA","title":"Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-03-01","conditions":"Atrial Fibrillation (AF)","enrollment":15360},{"nctId":"NCT07316270","phase":"NA","title":"SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracerebral Hemorrhage (SAFER-AF)","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-01","conditions":"AF - Atrial Fibrillation, ICH - Intracerebral Hemorrhage","enrollment":646},{"nctId":"NCT07314983","phase":"","title":"Long-term Anticoagulation in a Patient With Severe Hemophilia A","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2025-09-22","conditions":"Hemophilia A","enrollment":1},{"nctId":"NCT06388148","phase":"NA","title":"Endovascular Treatment for eXtra-Large Ischemic Stroke","status":"RECRUITING","sponsor":"Zhongming Qiu","startDate":"2024-06-16","conditions":"Stroke, Acute Ischemic","enrollment":286},{"nctId":"NCT07303816","phase":"PHASE4","title":"Statins to Prevent Cancer Associated Blood Clots","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-04-01","conditions":"Venous Thromboembolism, Cancer, Cardiovascular Events","enrollment":4000},{"nctId":"NCT05838664","phase":"","title":"A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-07-07","conditions":"Atrial Fibrillation","enrollment":2140403},{"nctId":"NCT07241130","phase":"","title":"Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2025-02-01","conditions":"Pulmonary Embolism Acute","enrollment":120},{"nctId":"NCT07115940","phase":"NA","title":"Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well","status":"NOT_YET_RECRUITING","sponsor":"Amrou Sarraj","startDate":"2026-01-01","conditions":"Acute Ischemic Stroke","enrollment":408},{"nctId":"NCT05089227","phase":"PHASE2","title":"Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2022-02-03","conditions":"Prolonged Anticoagulation, Venous Thromboembolic Disease, Autoimmune Hemolytic Anemia","enrollment":72},{"nctId":"NCT06912009","phase":"","title":"Duration of Therapeutic Anticoagulation in Patients With Pulmonary Embolism","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2024-11-06","conditions":"Pulmonary Embolism","enrollment":100},{"nctId":"NCT05399537","phase":"PHASE3","title":"Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT","status":"RECRUITING","sponsor":"Vantive Health LLC","startDate":"2024-07-12","conditions":"Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT), Acute Kidney Injury (AKI)","enrollment":40},{"nctId":"NCT03463317","phase":"PHASE4","title":"Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2018-02-28","conditions":"Atrial Fibrillation","enrollment":912},{"nctId":"NCT05646394","phase":"","title":"Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-07-01","conditions":"Antiphospholipid Syndrome, Arterial Thrombosis","enrollment":150},{"nctId":"NCT07119528","phase":"NA","title":"Application-Based Integrated Care in Patients After Pulse Field Ablation","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2025-07-21","conditions":"Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System","enrollment":500},{"nctId":"NCT06640114","phase":"NA","title":"Hemoperfusion With Efferon CT for the Treatment of Patients With Severe Psoriasis","status":"COMPLETED","sponsor":"Efferon JSC","startDate":"2024-10-22","conditions":"Psoriasis","enrollment":60},{"nctId":"NCT07185295","phase":"PHASE4","title":"Short-term Interruption Versus Continuous Anticoagulation in Colorectal Polypectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Outcomes'10","startDate":"2024-10-18","conditions":"Anticoagulated Patients","enrollment":481},{"nctId":"NCT06954610","phase":"","title":"Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-11-04","conditions":"Ischemic Stroke, Atrial Fibrillation, Cerebrovascular Disorders","enrollment":500},{"nctId":"NCT05782270","phase":"PHASE4","title":"Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy","status":"RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-04-11","conditions":"Anticoagulation, Coronary Endarterectomy","enrollment":202},{"nctId":"NCT07234383","phase":"PHASE1","title":"Accelerated HEmodiafiltration in Severe Acute Diquat (AHEAD) Poisoning","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2026-01-01","conditions":"Diquat Poisoning","enrollment":24},{"nctId":"NCT03407469","phase":"","title":"Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-01-12","conditions":"Cancer-related Venous Thromboembolism","enrollment":260},{"nctId":"NCT06966765","phase":"PHASE3","title":"Accelerated vs Standard Approach to Continuous Veno-venous Hemodiafiltration Post-hemoperfusion (ASAP) in Severe Acute Diquat Poisoning","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2027-01-01","conditions":"Diquat Poisoning","enrollment":267},{"nctId":"NCT05684796","phase":"NA","title":"Comparison of Two Pulmonary Embolism Treatments","status":"COMPLETED","sponsor":"Penumbra Inc.","startDate":"2023-11-27","conditions":"Pulmonary Embolism Acute","enrollment":100},{"nctId":"NCT01406353","phase":"NA","title":"Early Percutaneous Mitral Intervention in Asymptomatic Moderate Mitral Stenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asan Medical Center","startDate":"2011-07-29","conditions":"Moderate Mitral Stenosis","enrollment":167},{"nctId":"NCT04755283","phase":"PHASE2","title":"Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anthos Therapeutics, Inc.","startDate":"2021-02-02","conditions":"Atrial Fibrillation (AF), Stroke","enrollment":1287},{"nctId":"NCT04861103","phase":"PHASE4","title":"Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2020-10-01","conditions":"Pregnancy, High Risk, Anticoagulants","enrollment":12},{"nctId":"NCT06150742","phase":"NA","title":"Nafamostat Efficacy in Phase 3 Registrational CRRT Study","status":"RECRUITING","sponsor":"Talphera, Inc","startDate":"2024-08-15","conditions":"Acute Kidney Injury","enrollment":70},{"nctId":"NCT07214103","phase":"PHASE2","title":"Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2026-03-01","conditions":"Septic Shock, Coagulopathy","enrollment":120},{"nctId":"NCT02168829","phase":"PHASE4","title":"Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2016-01","conditions":"Atrial Fibrillation, Stroke","enrollment":1284},{"nctId":"NCT04617093","phase":"NA","title":"Post-Market Study of Low-flow ECCO2R Using PrismaLung+","status":"COMPLETED","sponsor":"Vantive Health LLC","startDate":"2021-04-30","conditions":"Mild to Moderate Acute Respiratory Distress Syndrome","enrollment":63},{"nctId":"NCT03761173","phase":"","title":"FlowTriever All-Comer Registry for Patient Safety and Hemodynamics","status":"COMPLETED","sponsor":"Inari Medical","startDate":"2018-12-15","conditions":"PE - Pulmonary Embolism, PE - Pulmonary Thromboembolism","enrollment":1200},{"nctId":"NCT07195760","phase":"","title":"Delayed IntraCranial Hemorrhage in Oral AntiCoagulant Treated Patients With Mild Traumatic Brain Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bispebjerg Hospital","startDate":"2023-02-10","conditions":"Head Trauma, Head Injury, Delirium","enrollment":600},{"nctId":"NCT06357403","phase":"","title":"Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2024-05-04","conditions":"Thrombosis, Pulmonary Embolism, Enoxaparin","enrollment":1300},{"nctId":"NCT06275555","phase":"NA","title":"Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation","status":"RECRUITING","sponsor":"Xiaotong Hou","startDate":"2024-06-03","conditions":"Extracorporeal Membrane Oxygenation Complication","enrollment":154},{"nctId":"NCT05180773","phase":"PHASE4","title":"Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy","status":"RECRUITING","sponsor":"Dennis M. McNamara, MD, MS","startDate":"2022-07-27","conditions":"Peripartum Cardiomyopathy, Postpartum","enrollment":250},{"nctId":"NCT07168278","phase":"PHASE3","title":"Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2025-11-01","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Tenecteplase","enrollment":794}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1954,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Therapeutic Anticoagulation","genericName":"Therapeutic Anticoagulation","companyName":"Unity Health Toronto","companyId":"unity-health-toronto","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Therapeutic anticoagulation involves the inhibition of blood clot formation to prevent thrombotic events. Used for Prevention of stroke and systemic embolism in non-valvular atrial fibrillation, Treatment and prevention of deep vein thrombosis and pulmonary embolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}